436 Modeling Approaches for Biological Phenomena II

Wednesday, October 31, 2012: 8:30 AM
Westmoreland East (Westin )
Description:
We invite submissions that describe the application of mathematical modeling to problems in the life sciences. Suggested topics include, but are not limited to, metabolism, signal transduction, and gene regulation. Preference will be given to submissions that directly link mathematical modeling with experimental data. Submissions that describe novel modeling approaches are also encouraged.

Sponsor:
Bioengineering

Chair:
Seda Kizilel
Email: skizilel@ku.edu.tr

Co-Chair:
Mariajose Castellanos
Email: mariajose@umbc.edu


8:30 AM
(436a) Comparison of the Isoprenoid Pathways in Marine Diatoms Using Isotope Assisted Metabolic Flux Analysis and Genome Scale Modeling
Andrew Quinn, Yuting Zheng, Steven Hutcheson and Ganesh Sriram

8:48 AM
(436b) Recent Computational Tools for the Analysis of Complex Biochemical Reaction Networks
Daniel Knight, Haixia Ji and Martin Feinberg

9:06 AM
(436c) Runge-Kutta Tau-Leaping Methods for Accelerating Stochastic Simulations of Biochemical Reaction Networks
Leonard A. Harris and James R. Faeder

9:24 AM
(436d) Mechanism of a Hotdog Fold Thioesterase-Catalyzed Reaction Proposed by QM/MM Metadynamics Simulation
David C. Cantu, Albert Ardevol, Carme Rovira and Peter J. Reilly

9:42 AM
(436e) Splitting Hill-Type Kinetics: Reduced, Modular, Stochastic Simulations
Patrick Smadbeck and Yiannis Kaznessis

10:00 AM
(436f) Use of 3-Dimensional Response Surface Plots for Heat Transport in the Human Eye to Predict Time of Death
Jimmy L. Smart

10:18 AM
(436g) Mapping the Cell Cycle in GS-NS0: Developing a Cyclin Blueprint As a Tool for Optimizing Productivity
D. G. Garcia Münzer, A. Mantalaris and E. N. Pistikopoulos

10:36 AM
(436h) Modeling Impact of Lipids On Orally Delivered Drug Dissolution
Selena Di Maio, David E. Budil and Rebecca L. Carrier
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division - See also TI: Comprehensive Quality by Design in Pharmaceutical Development and Manufacture
<< Previous Session | Next Session >>